|LETTER TO THE EDITOR
|Year : 2016 | Volume
| Issue : 6 | Page : 883-884
Reply to “How prevalent are depression and anxiety symptoms in hypothyroidism?”
Manish Bathla, Manpreet Singh
Department of Psychiatry, MM Institute of Medical Sciences and Research, Mullana, Ambala, Haryana, India
|Date of Web Publication||24-Oct-2016|
782, Sector 13, Urban Estate, Karnal, Haryana
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Bathla M, Singh M. Reply to “How prevalent are depression and anxiety symptoms in hypothyroidism?”. Indian J Endocr Metab 2016;20:883-4
|How to cite this URL:|
Bathla M, Singh M. Reply to “How prevalent are depression and anxiety symptoms in hypothyroidism?”. Indian J Endocr Metab [serial online] 2016 [cited 2020 Jun 2];20:883-4. Available from: http://www.ijem.in/text.asp?2016/20/6/883/192913
In response to letter to the editor by Praharaj et al. in Indian Journal of Endocrinology and Metabolism titled, “How prevalent are depression and anxiety symptoms in hypothyroidism?” The comments raised by the author are welcome.
We have noted the various points raised by the author in their letter and offer the appropriate explanations.
The patients with a history of anxiety and depression were excluded from our study  as the aim of the study was to assess prevalence among the patients diagnosed with hypothyroid and developed the anxiety and depressive symptoms later during illness (i.e., hypothyroid). The prevalence of depressive symptoms in hypothyroid population (more than 60%) is far more than that in general population (range from 1.5 to 19%).
Patients with below primary education were excluded so as to be able to differentiate between the onset of symptoms and the illness. However, we agree that these exclusions might have affected the actual prevalence of symptoms.
Although Hamilton depression rating scale and Hamilton anxiety rating scale are 17 points scale, the items which were not scored at all (i.e. zero) were not included in the statistics.
The recommendations by the authors are beyond the aims of the study; however, we had suggested this in view of the patient's response to the treatment and only a clinical tip for both the psychiatrist and the endocrinologists. This was done so as to emphasize the establishment of a liaison between the two.
The comparison with euthyroid individuals as controls would have led to the inclusion of other factors contributing to the depressive and anxiety symptoms. The details of the diagnosis of hypothyroid patients and the details of psychiatric diagnosis were beyond the scope of this study. Moreover, this has already been mentioned as the limitations of the study.
However, the points raised in the letter to the editor by Praharaj et al. with respect to the use of Bonferroni correction and also the Hospital Anxiety and Depression Scale are well taken up.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Bathla M, Singh M, Relan P. Prevalence of anxiety and depressive symptoms among patients with hypothyroidism. Indian J Endocrinol Metab 2016;20:468-74.
Demartini B, Masu A, Scarone S, Pontiroli AE, Gambini O. Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med 2010;52:277-82.
Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health 2013;34:119-38.